This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

William J. Mann, MD; Bruce Patsner, MD; Eva Chalas, MD
State University of New York at Stony Brook School of Medicine

JAMA. 1988;259(20):2999.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We are writing in response to the article on the use of interferon for treating condyloma¹ and the accompanying editorial,² which appeared in the Jan 22/29 issue of JAMA.

We are concerned about the adequacy of the evaluation given to female patients before the start of therapy. In our experience, 68% of patients referred with vulval condyloma had biopsyproved cervical and vaginal pathology.³ In the absence of colposcopic evaluation, how are we to be sure that the patients treated in this study did not indeed have vaginal and cervical lesions? If we accept this possibility, then the results are called into question. Did the patient who had a vulval response also have responsive internal lesions? Or are the patients who failed to respond those patients in whom vaginal and cervical lesions were present and not treated? We are particularly concerned since in our experience . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?